Raymond Debbane Net Worth & Insider Trades
Raymond Debbane - Director, Lexicon Pharmaceuticals, Inc
What is Raymond Debbane's Net Worth?
The current estimated net worth of Lexicon Pharmaceuticals, Inc's Director, Raymond Debbane, is estimated to be about $3.41M . Raymond Debbane owns about 5,782,749 units of Lexicon Pharmaceuticals, Inc common stock. In the last 16 years at Lexicon Pharmaceuticals, Inc, Raymond Debbane has sold an estimated value of $0 worth.
What is Raymond Debbane's Past Insider Trading?
Raymond Debbane's largest purchase order was 50,824,986 units , worth over $205.47M on August 24, 2007. In total, Raymond Debbane has made about 32 transactions over 16 years of their time at Lexicon Pharmaceuticals, Inc. Raymond Debbane usually trades in April, with the busiest year in 2022. The most recent transaction was a purchase order of 147,390 units , worth over $368.48K on August 9, 2022.
Raymond Debbane
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Raymond Debbane's' Mailing Address?
- Mailing address is C/o the Invus Group, Llc 750 Lexington Avenue New York NY 10022 NY
What are Lexicon Pharmaceuticals, Inc's Past Insider Trades?
Lexicon Pharmaceuticals, Inc's most recent insider trade came on August 9, 2022 by Invus Us Partners Llc, Ulys Llc and Raymond Debbane who bought 147,390 units worth $368.48K . In the last 15 years, insiders at Lexicon Pharmaceuticals, Inc have sold an estimated value of $4.48M and bought an estimated value of $787.45M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Raymond Debbane, Director, Jeffrey L Wade, President and CFO, and Alan J Main, EVP .
LEXICON PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||